Tranilast
Sponsors
Hirata Hitoshi, Imperial College London, Nuon Therapeutics, Inc., The First Affiliated Hospital with Nanjing Medical University, Peking Union Medical College Hospital
Conditions
Active Rheumatoid ArthritisCryopyrin-Associated Periodic SyndromesEsophageal NeoplasmsEsophageal StrictureGoutHyperuricemiaMucinosesNLRP3
Early Phase 1
A Clinical Study of Tranilast in the Treatment of Mucinoses
NCT03490708
Start: 2018-04-30End: 2022-12-31Target: 56Updated: 2018-04-06
A Clinical Study of Tranilast in the Treatment of Scleredema Diabeticorum
NCT03512873
Start: 2018-06-30End: 2020-12-31Target: 56Updated: 2018-05-01
A Clinical Study of Tranilast in the Treatment of Sarcoidosis
NCT03528070
Start: 2018-05-31End: 2020-12-31Target: 56Updated: 2018-05-17
Phase 1
Phase 2
Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)
CompletedNCT00882024
Start: 2009-03-31End: 2010-12-31Target: 250Updated: 2011-01-06
Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia
CompletedNCT00995618
Start: 2009-09-30End: 2010-04-30Updated: 2011-01-06
Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia
CompletedNCT01052987
Start: 2010-01-31End: 2010-11-30Target: 24Updated: 2011-01-06
A Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)
NCT03923140
Start: 2019-05-23End: 2024-10-31Target: 71Updated: 2019-06-04
Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma
NCT05626829
Start: 2022-07-20End: 2024-11-30Target: 18Updated: 2023-10-06
Tranilast Vs. Steroids to Prevent Esophageal Stricture (TAPES) After Endoscopic Resection for Superficial Neoplasms
Not yet recruitingNCT06643689
Start: 2025-01-01End: 2028-12-31Target: 394Updated: 2024-11-14
Phase 4
Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI
CompletedNCT05130892
Start: 2021-11-15End: 2023-02-01Updated: 2023-02-08
Efficacy and Safety of Tranilast Combined With Minocycline in the Treatment of Rosacea
Enrolling by invitationNCT06307288
Start: 2023-10-16End: 2024-06-01Target: 45Updated: 2024-03-12